EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 191 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $205,825 | 0.0% | 7,255 | 0.0% | 0.00% | – |
| Q1 2023 | $205,825 | -9.7% | 7,255 | -7.0% | 0.00% | – |
| Q4 2022 | $227,965 | -99.9% | 7,799 | 0.0% | 0.00% | – |
| Q3 2022 | $206,049,000 | -64.2% | 7,799 | -39.7% | 0.00% | – |
| Q2 2022 | $575,013,000 | -13.5% | 12,942 | -3.6% | 0.00% | – |
| Q1 2022 | $664,452,000 | +8.9% | 13,426 | +12.0% | 0.00% | – |
| Q4 2021 | $610,174,000 | -7.1% | 11,983 | +1.8% | 0.00% | – |
| Q3 2021 | $656,643,000 | +135.0% | 11,772 | +80.3% | 0.00% | – |
| Q2 2021 | $279,441,000 | +2.5% | 6,529 | 0.0% | 0.00% | – |
| Q1 2021 | $272,521,000 | -10.4% | 6,529 | 0.0% | 0.00% | – |
| Q4 2020 | $304,056,000 | +9.6% | 6,529 | 0.0% | 0.00% | – |
| Q3 2020 | $277,351,000 | -11.5% | 6,529 | 0.0% | 0.00% | – |
| Q2 2020 | $313,261,000 | +6.4% | 6,529 | +2.0% | 0.00% | – |
| Q1 2020 | $294,446,000 | -51.5% | 6,401 | -36.7% | 0.00% | – |
| Q4 2019 | $607,710,000 | +60.3% | 10,115 | +50.9% | 0.00% | – |
| Q3 2019 | $379,076,000 | +1.6% | 6,701 | 0.0% | 0.00% | – |
| Q2 2019 | $373,112,000 | +10.3% | 6,701 | 0.0% | 0.00% | – |
| Q1 2019 | $338,333,000 | +58.4% | 6,701 | +26.4% | 0.00% | – |
| Q4 2018 | $213,537,000 | -41.9% | 5,300 | 0.0% | 0.00% | – |
| Q3 2018 | $367,449,000 | -8.4% | 5,300 | 0.0% | 0.00% | – |
| Q2 2018 | $400,998,000 | +163572.7% | 5,300 | +51.4% | 0.00% | – |
| Q3 2016 | $245,000 | -29.2% | 3,500 | -10.3% | 0.00% | – |
| Q4 2015 | $346,000 | +19.7% | 3,900 | 0.0% | 0.00% | – |
| Q3 2015 | $289,000 | +2.1% | 3,900 | +11.4% | 0.00% | – |
| Q2 2015 | $283,000 | – | 3,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ProQuest Associates IV LLC | 3,652,284 | $302,920,000 | 91.10% |
| Hudson Executive Capital LP | 1,901,200 | $157,686,000 | 21.62% |
| JW Asset Management, LLC | 525,755 | $43,606,000 | 9.08% |
| Cormorant Asset Management, LP | 200,000 | $16,588,000 | 2.41% |
| Park West Asset Management LLC | 488,128 | $40,485,000 | 2.36% |
| Opaleye Management Inc. | 50,000 | $4,147,000 | 2.06% |
| Ranger Investment Management | 283,954 | $23,551,000 | 1.71% |
| Pier Capital, LLC | 74,732 | $6,198,000 | 1.06% |
| Bellevue Group AG | 67,700 | $5,615,000 | 0.75% |
| Orbimed Advisors | 671,000 | $55,653,000 | 0.63% |